Abbvie Inc (ABBV)

05:10 AM

Is AbbVie’s 30% 2025 Surge Justified by Its Latest Drug Pipeline Wins? - Yahoo Finance

05:10 AM

02:57 AM

AbbVie Gets FDA Approval for Epkinly Combo for Relapsed Follicular Lymphoma - MarketScreener

02:57 AM

01:43 AM

AbbVie Announces U.S. FDA Approval of EPKINLY® in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma - Investing News Network

01:43 AM

01:38 AM

FDA approves AbbVie’s EPKINLY combination therapy for lymphoma By Investing.com - Investing.com Canada

01:38 AM

01:31 AM

FDA Approves AbbVie's EPKINLY for Follicular Lymphoma Treatment - GuruFocus

01:31 AM

12:04 PM

FDA Expands Approval for AbbVie's (ABBV) Epkinly in Lymphoma Tre - GuruFocus

12:04 PM

11:34 AM

AbbVie, Genmab win FDA label expansion for Epkinly (GMAB) - Seeking Alpha

11:34 AM

09:37 AM

Here's How Neuroscience Drugs Aided AbbVie's Top-line Growth in Q3 - Nasdaq

09:37 AM

07:09 AM

Will AbbVie Inc. stock announce special dividendGap Up & Free Technical Confirmation Trade Alerts - newser.com

07:09 AM

05:39 AM

AbbVie's (NYSE:ABBV) Dividend Will Be Increased To $1.73 - simplywall.st

05:39 AM

04:46 AM

Analyst recommendations: Alphabet, Amazon, Microsoft, AbbVie, Comcast… - MarketScreener

04:46 AM

03:01 AM

How AbbVie Inc. stock performs in easing cycles2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com

03:01 AM

Nov 17, 2025

Enanta Pharmaceuticals Q4 revenue rises, helped by higher sales of AbbVie's MAVYRET/MAVIRET - TradingView

Nov 17, 2025

Nov 17, 2025

A Look Into AbbVie Inc's Price Over Earnings - Benzinga

Nov 17, 2025

Nov 17, 2025

AbbVie (ABBV) Gains Health Canada Approval for New Lupron Depot Dosage - GuruFocus

Nov 17, 2025

Nov 17, 2025

AbbVie Stock Falls 4% -- What Investors Need to Know - Finviz

Nov 17, 2025

Nov 17, 2025

LUPRON DEPOT® new strength receives Health Canada Approval for the Treatment of Advanced Prostate Cancer - Investing News Network

Nov 17, 2025

Nov 17, 2025

Filmmaker helps AbbVie spread the word about leukaemia - pharmaphorum

Nov 17, 2025

Nov 17, 2025

AbbVie Stock Falls 4% -- What Investors Need to Know - The Motley Fool

Nov 17, 2025

Nov 16, 2025

Why AbbVie Inc. stock appears on watchlists2025 Market WrapUp & Daily Price Action Insights - newser.com

Nov 16, 2025

Nov 16, 2025

Is AbbVie Inc. (4AB) stock a buy before earnings resultsWeekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com

Nov 16, 2025

Nov 16, 2025

Can AbbVie Inc. (Common Stock) (4AB0) stock retain market dominance2025 Year in Review & Growth Oriented Trade Recommendations - newser.com

Nov 16, 2025

Nov 16, 2025

Analyzing AbbVie Inc. with risk reward ratio chartsWeekly Stock Summary & Daily Stock Trend Reports - newser.com

Nov 16, 2025

Nov 16, 2025

Will AbbVie Inc. stock attract more institutional investorsJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com

Nov 16, 2025

Nov 16, 2025

How AbbVie Inc. stock trades before earningsJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com

Nov 16, 2025

Nov 16, 2025

Is AbbVie Inc. (4AB) stock undervalued after correctionJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com

Nov 16, 2025

Nov 16, 2025

AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.73 - Yahoo Finance

Nov 16, 2025

Nov 16, 2025

How AbbVie Inc. (Common Stock) (4AB0) stock performs during market turbulenceJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com

Nov 16, 2025

Nov 15, 2025

How reliable is AbbVie Inc. (4AB) stock dividend growthJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com

Nov 15, 2025

Nov 15, 2025

AbbVie Inc 4AB Stock Analysis and ForecastMarket Liquidity Analysis & Learn the Secrets of Pro Traders - earlytimes.in

Nov 15, 2025

Nov 14, 2025

How higher bond yields impact AbbVie Inc. stockTrade Volume Summary & Fast Exit and Entry Trade Guides - newser.com

Nov 14, 2025

Nov 14, 2025

Will AbbVie Inc. stock beat EPS estimates2025 Top Gainers & Reliable Price Breakout Alerts - newser.com

Nov 14, 2025

Nov 14, 2025

AbbVie Partners with Award-Winning Filmmaker on Film About the Dynamic and Resilient Lives of Those Living with Blood Cancer - Investing News Network

Nov 14, 2025

Nov 14, 2025

AbbVie (NYSE: ABBV) debuts Second Winds CLL film; YouTube, Documentary+ in Dec 2025 - Stock Titan

Nov 14, 2025

Nov 14, 2025

Mubadala Investment Co PJSC reports share stake in Adobe, Verizon, dissolves in RTX, AbbVie - MarketScreener

Nov 14, 2025

Nov 14, 2025

Abbvie describes new LPAR1 antagonists - BioWorld MedTech

Nov 14, 2025

Nov 14, 2025

Is AbbVie Inc 4AB a good long term investmentExit Strategy Tips & Discover High-Return Stocks Before They Boom - earlytimes.in

Nov 14, 2025

Nov 14, 2025

AbbVie exits $1.5 billion longevity drug deal with Calico: report - Crain's Chicago Business

Nov 14, 2025

Nov 14, 2025

Why millennials buy AbbVie Inc. (Common Stock) (4AB0) stockQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com

Nov 14, 2025

Nov 14, 2025

Can AbbVie Inc. stock sustain revenue growthEarnings Growth Report & Stepwise Swing Trade Plans - newser.com

Nov 14, 2025

Nov 13, 2025

The Fight to Save the $2.7 Billion Botox Empire - Bloomberg.com

Nov 13, 2025

Nov 13, 2025

Is AbbVie Inc. stock undervalued vs historical averages2025 Geopolitical Influence & Proven Capital Preservation Methods - newser.com

Nov 13, 2025

Nov 13, 2025

Is AbbVie Inc. stock undervalued at current price2025 Technical Overview & Daily Stock Trend Watchlist - newser.com

Nov 13, 2025

Nov 13, 2025

Why AbbVie Inc. (4AB) stock stays on top picksWeekly Stock Summary & Consistent Income Trade Recommendations - newser.com

Nov 13, 2025

Nov 13, 2025

How AbbVie Inc. (4AB) stock benefits from digital adoptionWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com

Nov 13, 2025

Nov 13, 2025

UCB’s Bimzelx and AbbVie’s Rinvoq Lead in EU5 Psoriatic Arthritis, Ankylosing Spondylitis, and Non-Radiographic Axial Spondyloarthritis Growth - The Manila Times

Nov 13, 2025

Nov 13, 2025

UCB’s Bimzelx and AbbVie’s Rinvoq Lead in EU5 Psoriatic - GlobeNewswire

Nov 13, 2025

Nov 13, 2025

What Wall Street predicts for AbbVie Inc. stock pricePortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com

Nov 13, 2025

Nov 13, 2025

Argus Raises AbbVie's Price Target to $250 From $220 - MarketScreener

Nov 13, 2025

Nov 13, 2025

Can momentum traders help lift AbbVie Inc.IPO Watch & Consistent Growth Stock Picks - newser.com

Nov 13, 2025

Nov 13, 2025

AbbVie Announces 20 Recipients of Migraine Career Catalyst Award - Investing News Network

Nov 13, 2025

Nov 13, 2025

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More - MSN

Nov 13, 2025

Nov 13, 2025

AbbVie ends 11-year relationship with Calico, lays off 100+ - PharmaLive

Nov 13, 2025

Nov 13, 2025

AbbVie Ends 11-Year Relationship With Calico, Lays Off 100+ - BioSpace

Nov 13, 2025

Nov 13, 2025

AbbVie Announces 20 Recipients of Migraine Career Catalyst Award™ - Yahoo Finance

Nov 13, 2025

Nov 13, 2025

AbbVie exits alliance with Alphabet biotech Calico; report - pharmaphorum

Nov 13, 2025

Nov 13, 2025

Chiesi licenses AbbVie subsidiary's BBB platform - The Pharma Letter

Nov 13, 2025